AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinker, K.
Right arrow Articles by Trattnig, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinker, K.
Right arrow Articles by Trattnig, S.

BRAIN

High-Resolution Contrast-Enhanced, Susceptibility-Weighted MR Imaging at 3T in Patients with Brain Tumors: Correlation with Positron-Emission Tomography and Histopathologic Findings

K. Pinkera, I.M. Noebauer-Huhmanna, I. Stavroub, R. Hoeftbergerc, P. Szomolanyia, G. Karanikasd, M. Webera, A. Stadlbauere, E. Knospb, K. Friedricha and S. Trattniga

a MR Centre of Excellence, Department of Radiology, Medical University Vienna, Vienna, Austria
b Department of Neurosurgery, Medical University Vienna, Vienna, Austria
c Institute of Neurology, Medical University Vienna, Vienna, Austria
d Department of Nuclear Medicine, Medical University Vienna, Vienna, Austria
e Department of Neurosurgery, University Erlangen-Nuremberg, Erlangen, Germany

Address correspondence to Siegfried Trattnig, MR Centre of Excellence, Department of Radiology, Medical University Vienna, Lazarettg 14, 1090 Vienna, Austria; e-mail: siegfried.trattnig{at}meduniwien.ac.at

BACKGROUND AND PURPOSE: The purpose of this work was to demonstrate susceptibility effects (SusE) in various types of brain tumors with 3T high-resolution (HR)-contrast-enhanced (CE)-susceptibility-weighted (SW)-MR imaging and to correlate SusE with positron-emission tomography (PET) and histopathology.

MATERIALS AND METHODS: Eighteen patients with brain tumors, scheduled for biopsy or tumor extirpation, underwent high-field (3T) MR imaging. In all of the patients, an axial T1-spin-echo (SE) sequence and an HR-SW imaging sequence before and after IV application of a standard dose of contrast agent (MultiHance) was obtained. Seven patients preoperatively underwent PET. The frequency and formation of intralesional SusE in all of the images were evaluated and correlated with tumor grade as determined by PET and histopathology. Direct correlation of SusE and histopathologic specimens was performed in 6 patients. Contrast enhancement of the lesions was assessed in both sequences.

RESULTS: High-grade lesions demonstrated either high or medium frequency of SusE in 90% of the patients. Low-grade lesions demonstrated low frequency of SusE or no SusE. Correlation between intralesional frequency of SusE and histopathologic, as well as PET, tumor grading was statistically significant. Contrast enhancement was equally visible in both SW and SE sequences. Side-to-side comparison of tumor areas with high frequency of SusE and histopathology revealed that intralesional SusE reflected conglomerates of increased tumor microvascularity.

CONCLUSIONS: 3T HR-CE-SW-MR imaging shows both intratumoral SusE not visible with standard MR imaging and contrast enhancement visible with standard MR imaging. Because frequency of intratumoral SusE correlates with tumor grade as determined by PET and histopathology, this novel technique is a promising tool for noninvasive differentiation of low-grade from high-grade brain tumors and for determination of an optimal area of biopsy for accurate tumor grading.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
H.S. Kim, G.-H. Jahng, C.W. Ryu, and S.Y. Kim
Added Value and Diagnostic Performance of Intratumoral Susceptibility Signals in the Differential Diagnosis of Solitary Enhancing Brain Lesions: Preliminary Study
AJNR Am. J. Neuroradiol., September 1, 2009; 30(8): 1574 - 1579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M.J. Park, H.S. Kim, G.-H. Jahng, C.-W. Ryu, S.M. Park, and S.Y. Kim
Semiquantitative Assessment of Intratumoral Susceptibility Signals Using Non-Contrast-Enhanced High-Field High-Resolution Susceptibility-Weighted Imaging in Patients with Gliomas: Comparison with MR Perfusion Imaging
AJNR Am. J. Neuroradiol., August 1, 2009; 30(7): 1402 - 1408.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R.N.K. Nandigam, A. Viswanathan, P. Delgado, M.E. Skehan, E.E. Smith, J. Rosand, S.M. Greenberg, and B.C. Dickerson
MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength
AJNR Am. J. Neuroradiol., February 1, 2009; 30(2): 338 - 343.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
E.M. Haacke, S. Mittal, Z. Wu, J. Neelavalli, and Y.-C.N. Cheng
Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1
AJNR Am. J. Neuroradiol., January 1, 2009; 30(1): 19 - 30.
[Abstract] [Full Text] [PDF]